308 related articles for article (PubMed ID: 23896378)
21. Emerging field of metabolomics: big promise for cancer biomarker identification and drug discovery.
Patel S; Ahmed S
J Pharm Biomed Anal; 2015 Mar; 107():63-74. PubMed ID: 25569286
[TBL] [Abstract][Full Text] [Related]
22. 1H-NMR based metabonomic profiling of human esophageal cancer tissue.
Wang L; Chen J; Chen L; Deng P; Bu Q; Xiang P; Li M; Lu W; Xu Y; Lin H; Wu T; Wang H; Hu J; Shao X; Cen X; Zhao YL
Mol Cancer; 2013 Apr; 12():25. PubMed ID: 23556477
[TBL] [Abstract][Full Text] [Related]
23. Metabolomic investigation of gastric cancer tissue using gas chromatography/mass spectrometry.
Wu H; Xue R; Tang Z; Deng C; Liu T; Zeng H; Sun Y; Shen X
Anal Bioanal Chem; 2010 Feb; 396(4):1385-95. PubMed ID: 20012946
[TBL] [Abstract][Full Text] [Related]
24. Metabolomics of gastric cancer metastasis detected by gas chromatography and mass spectrometry.
Chen JL; Tang HQ; Hu JD; Fan J; Hong J; Gu JZ
World J Gastroenterol; 2010 Dec; 16(46):5874-80. PubMed ID: 21155010
[TBL] [Abstract][Full Text] [Related]
25. Use of Metabolomics as a Complementary Omic Approach to Implement Risk Criteria for First-Degree Relatives of Gastric Cancer Patients.
Corona G; Cannizzaro R; Miolo G; Caggiari L; De Zorzi M; Repetto O; Steffan A; De Re V
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29518896
[TBL] [Abstract][Full Text] [Related]
26. Potential role of metabolomics in diagnosis and surveillance of gastric cancer.
Chan AW; Gill RS; Schiller D; Sawyer MB
World J Gastroenterol; 2014 Sep; 20(36):12874-82. PubMed ID: 25278684
[TBL] [Abstract][Full Text] [Related]
27. Metabolome analysis of esophageal cancer tissues using capillary electrophoresis-time-of-flight mass spectrometry.
Tokunaga M; Kami K; Ozawa S; Oguma J; Kazuno A; Miyachi H; Ohashi Y; Kusuhara M; Terashima M
Int J Oncol; 2018 Jun; 52(6):1947-1958. PubMed ID: 29620160
[TBL] [Abstract][Full Text] [Related]
28. Serum metabolomics differentiating pancreatic cancer from new-onset diabetes.
He X; Zhong J; Wang S; Zhou Y; Wang L; Zhang Y; Yuan Y
Oncotarget; 2017 Apr; 8(17):29116-29124. PubMed ID: 28418859
[TBL] [Abstract][Full Text] [Related]
29. Metabolomic biomarkers of low BMD: a systematic review.
Panahi N; Arjmand B; Ostovar A; Kouhestani E; Heshmat R; Soltani A; Larijani B
Osteoporos Int; 2021 Dec; 32(12):2407-2431. PubMed ID: 34309694
[TBL] [Abstract][Full Text] [Related]
30. Mass Spectrometric Analysis of Exhaled Breath for the Identification of Volatile Organic Compound Biomarkers in Esophageal and Gastric Adenocarcinoma.
Kumar S; Huang J; Abbassi-Ghadi N; Mackenzie HA; Veselkov KA; Hoare JM; Lovat LB; Španěl P; Smith D; Hanna GB
Ann Surg; 2015 Dec; 262(6):981-90. PubMed ID: 25575255
[TBL] [Abstract][Full Text] [Related]
31. Discriminating gastric cancer and gastric ulcer using human plasma amino acid metabolic profile.
Jing F; Hu X; Cao Y; Xu M; Wang Y; Jing Y; Hu X; Gao Y; Zhu Z
IUBMB Life; 2018 Jun; 70(6):553-562. PubMed ID: 29626382
[TBL] [Abstract][Full Text] [Related]
32. Potential metabolomic biomarkers for evaluation of adriamycin efficacy using a urinary 1H-NMR spectroscopy.
Kim KB; Yang JY; Kwack SJ; Kim HS; Ryu DH; Kim YJ; Bae JY; Lim DS; Choi SM; Kwon MJ; Bang DY; Lim SK; Kim YW; Hwang GS; Lee BM
J Appl Toxicol; 2013 Nov; 33(11):1251-9. PubMed ID: 22782856
[TBL] [Abstract][Full Text] [Related]
33. Serum metabolomic profiling of prostate cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial.
Huang J; Mondul AM; Weinstein SJ; Koutros S; Derkach A; Karoly E; Sampson JN; Moore SC; Berndt SI; Albanes D
Br J Cancer; 2016 Oct; 115(9):1087-1095. PubMed ID: 27673363
[TBL] [Abstract][Full Text] [Related]
34. Serum metabolomic profiling in acute alcoholic hepatitis identifies multiple dysregulated pathways.
Rachakonda V; Gabbert C; Raina A; Bell LN; Cooper S; Malik S; Behari J
PLoS One; 2014; 9(12):e113860. PubMed ID: 25461442
[TBL] [Abstract][Full Text] [Related]
35. Metabolomic investigation of Arthus reaction in a rat model using proton nuclear magnetic resonance (1H NMR) spectroscopy and rapid resolution liquid chromatography (RRLC).
Zhang X; Shen J; Cao B; Xu L; Zhao T; Liu X; Zhang H
Mol Biosyst; 2013 Jun; 9(6):1423-35. PubMed ID: 23511749
[TBL] [Abstract][Full Text] [Related]
36. Metabolomic and BH3 profiling of esophageal cancers: novel assessment methods for precision therapy.
Taylor Ripley R; Surman DR; Diggs LP; Trepel JB; Lee MJ; Ryan J; Davis JL; Steinberg SM; Hernandez JM; Hoang C; Kenney CM; Bond CD; Kunst TF; Letai A; Schrump DS
BMC Gastroenterol; 2018 Jun; 18(1):94. PubMed ID: 29933761
[TBL] [Abstract][Full Text] [Related]
37. Glucose metabolism in gastric cancer: The cutting-edge.
Yuan LW; Yamashita H; Seto Y
World J Gastroenterol; 2016 Feb; 22(6):2046-59. PubMed ID: 26877609
[TBL] [Abstract][Full Text] [Related]
38. Gastric cancer: Metabolic and metabolomics perspectives (Review).
Xiao S; Zhou L
Int J Oncol; 2017 Jul; 51(1):5-17. PubMed ID: 28535006
[TBL] [Abstract][Full Text] [Related]
39. Metabolomic Analysis of Gastric Cancer Progression within the Correa's Cascade Using Ultraperformance Liquid Chromatography-Mass Spectrometry.
Kuligowski J; Sanjuan-Herráez D; Vázquez-Sánchez MA; Brunet-Vega A; Pericay C; Ramírez-Lázaro MJ; Lario S; Gombau L; Junquera F; Calvet X; Quintás G
J Proteome Res; 2016 Aug; 15(8):2729-38. PubMed ID: 27384260
[TBL] [Abstract][Full Text] [Related]
40. NMR-based metabolomic techniques identify potential urinary biomarkers for early colorectal cancer detection.
Wang Z; Lin Y; Liang J; Huang Y; Ma C; Liu X; Yang J
Oncotarget; 2017 Dec; 8(62):105819-105831. PubMed ID: 29285295
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
